CLINICAL CHARACTERISTICS OF OCULAR ADNEXAL MARGINAL ZONE NON HODGKIN LYMPHOMA
Main Article Content
Abstract
Ocular adnexal marginal zone non Hodgkin lymphoma is a distinct and rare group of diseases. The study describes a series of cases conducted on 56 patients with marginal zone non-Hodgkin's lymphoma in ocular adnexa at the Department of Hematological oncology, K Hospital from March 2019 to June 2023, to evaluate some Clinical features of this distinct group of diseases. The results showed: average age 59.2 years old, majority of men (69.6%) and good performance status (PS= 0 (60.7%), PS=1 1 (35.7%)), reason Admission to the hospital was mainly due to palpable tumors (21.4%) and eye symptoms such as eyelid edema (19.6%), bulging eyes (19.6%), eye pain (16.1%), and the time of appearance is mainly less than 6 months (44.6%), the location of onset is mainly in the eye adnexa (71.4%); tumor location of the orbit (66.1%), eyelids (12.5%), lacrimal gland (12.5%), conjunctiva (8.9%); Most tumors were 2-4 cm in size (57.1%), stage I (48.2%), low risk (92.8%), Ki67 <5% (58.9%), the rate increases LDH and uric acid were low (1.8% and 8.9%, respectively).
Article Details
Keywords
marginal zone non Hodgkin lymphoma, ocular adnexal
References
2. Khalil MO, Morton LM, Devesa SS, et al. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. Br J Haematol. 2014;165(1):67-77. doi:10.1111/bjh.12730
3. Borie R, Wislez M, Thabut G, et al. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma. European Respiratory Journal. 2009; 34(6): 1408-1416. doi: 10.1183/ 09031936.00039309
4. Demirci H, Shields CL, Karatza EC, Shields JA. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases. Ophthalmology. 2008;115(9):1626-1631, 1631.e1-3. doi:10.1016/j.ophtha.2008.02.004
5. Rosado MF, Byrne GE, Ding F, et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood. 2006; 107(2): 467-472. doi:10.1182/blood-2005-06-2332
6. Fernández CA, Henry RK, Shields CL, et al. Ocular adnexal lymphoma: A single-institution retrospective study. Saudi J Ophthalmol. 2021; 35(3): 230-238. doi: 10.4103/1319-4534. 343368
7. Ma WL, Yao M, Liao SL, et al. Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas. Oncotarget. 2017; 8(46): 81329-81342. doi:10. 18632/oncotarget.18500
8. Zucca E, Conconi A, Martinelli G, et al. Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. J Clin Oncol. 2017;35(17): 1905-1912. doi:10.1200/ JCO.2016.70.699